SEC Form 10-Q filed by Cronos Group Inc.
$CRON
Medicinal Chemicals and Botanical Products
Health Care
Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/27/2026 | Buy | Canaccord Genuity | |
| 11/2/2022 | $3.00 | Mkt Perform | Bernstein |
| 7/28/2022 | Hold → Buy | Canaccord Genuity | |
| 5/11/2022 | Neutral → Sector Outperform | CIBC | |
| 3/22/2022 | Underweight → Equal Weight | Barclays | |
| 3/7/2022 | $4.00 → $3.00 | Neutral | Piper Sandler |
| 2/22/2022 | $7.00 → $4.25 | Sell | Canaccord Genuity |
| 2/22/2022 | $7.00 → $4.00 | Neutral | Piper Sandler |
8-K - Cronos Group Inc. (0001656472) (Filer)
10-Q - Cronos Group Inc. (0001656472) (Filer)
8-K - Cronos Group Inc. (0001656472) (Filer)
Canaccord Genuity initiated coverage of Cronos Group with a rating of Buy
Bernstein initiated coverage of Cronos Group with a rating of Mkt Perform and set a new price target of $3.00
Canaccord Genuity upgraded Cronos Group from Hold to Buy
TORONTO, July 21, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos"), an innovative global cannabis company, is expanding its lineup of SOURZ by Spinach® Fully Blasted multipacks to meet consumer demand for edible products during the summer season. The lineup of SOURZ by Spinach® Fully Blasted multipacks with liquid diamond-infused gummies now includes the brand’s popular flavors featuring rare cannabinoid formulations, along with a new limited-time offer (LTO) flavor for the summer months. SOURZ by Spinach® Fully Blasted multipacks are the #1 edible multipack in Canada, capturing 31.7% share of all 10x10 pack sales in May 2026¹. The Spinach® brand continues to
TORONTO, July 16, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") will hold its 2026 second quarter earnings conference call on Thursday, August 6, 2026 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/events-presentations. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast of the call will be archived for replay o
TORONTO, June 30, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. ("Cronos" or the "Company") (NASDAQ:CRON) (TSX:CRON), an innovative global cannabis company, announced today that it has appointed ATB Capital Markets Corp. ("ATB Cormark") to act as its broker in connection with share repurchases over the facilities of the TSX or other alternative Canadian trading systems, in place of Virtu Canada Corp., under its previously announced share repurchase program. About Cronos Cronos is a global cannabis company focused on scaling leading consumer goods products through research and development and innovation. With a passion to responsibly elevate the consumer experience, Cronos is building an ico
3 - Cronos Group Inc. (0001656472) (Issuer)
4 - Cronos Group Inc. (0001656472) (Issuer)
4 - Cronos Group Inc. (0001656472) (Issuer)
TORONTO, July 16, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") will hold its 2026 second quarter earnings conference call on Thursday, August 6, 2026 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/events-presentations. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast of the call will be archived for replay o
TORONTO, April 20, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") will hold its 2026 first quarter earnings conference call on Monday, May 11, 2026 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/events-presentations. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast of the call will be archived for replay on th
TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") will hold its 2025 fourth quarter and full-year earnings conference call on Thursday, February 26, 2026 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/events-presentations. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast of the call will be arch
TORONTO, June 30, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. ("Cronos" or the "Company") (NASDAQ:CRON) (TSX:CRON), an innovative global cannabis company, announced today that it has appointed ATB Capital Markets Corp. ("ATB Cormark") to act as its broker in connection with share repurchases over the facilities of the TSX or other alternative Canadian trading systems, in place of Virtu Canada Corp., under its previously announced share repurchase program. About Cronos Cronos is a global cannabis company focused on scaling leading consumer goods products through research and development and innovation. With a passion to responsibly elevate the consumer experience, Cronos is building an ico
TORONTO, June 22, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") today announced that at its Annual Meeting of Shareholders held on Thursday, June 18, 2026 (the "Meeting"), shareholders holding a total of 271,828,759 common shares of the Company voted in person or by proxy, representing 72.24% of the total number of common shares of the Company outstanding. Each of the directors listed as a nominee in the Company’s definitive proxy statement dated April 24, 2026, was elected as a director of the Company, with each director receiving in excess of 93.6% of the votes cast in favor of his or her election. The detailed results of the vote for th
TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") today announced that at its Annual Meeting of Shareholders held on Friday, June 20, 2025 (the "Meeting"), shareholders holding a total of 276,989,452 common shares of the Company voted in person or by proxy, representing 71.87% of the total number of common shares of the Company outstanding. Each of the directors listed as a nominee in the Company's definitive proxy statement dated April 25, 2025 was elected as a director of the Company, with each director receiving in excess of 92.3% of the votes cast in favor of his or her election. The detailed results of the vote for the e
SC 13D/A - Cronos Group Inc. (0001656472) (Subject)
SC 13D/A - Cronos Group Inc. (0001656472) (Subject)